CAPSAICIN

CAPSAICIN was reported 3424 times

CAPSAICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URTICARIA CONTACT 5 0.1389
1 APPLICATION SITE JOINT ERYTHEMA 1 0.1111
2 BODY TINEA 57 0.1018
3 APPLICATION SITE HYPERAESTHESIA 10 0.1010
4 APPLICATION SITE HYPOAESTHESIA 21 0.0897
5 APPLICATION SITE PLAQUE 2 0.0870
6 APPLICATION SITE NECROSIS 8 0.0777
7 APPLICATION SITE MACULE 1 0.0667
8 APPLICATION SITE COLD FEELING 1 0.0556
9 BURNS FIRST DEGREE 12 0.0421
10 INTRAPARTUM HAEMORRHAGE 3 0.0375
11 SERRATIA BACTERAEMIA 5 0.0338
12 INHIBITORY DRUG INTERACTION 53 0.0335
13 ABDOMINAL BRUIT 1 0.0333
14 COMPLEMENT FACTOR C4 DECREASED 6 0.0312
15 STERILE PYURIA 2 0.0312
16 APPLICATION SITE WARMTH 39 0.0306
17 APPLICATION SITE PAIN 628 0.0285
18 INFECTION SUSCEPTIBILITY INCREASED 57 0.0260
19 BURNS SECOND DEGREE 44 0.0251
20 APPLICATION SITE OEDEMA 8 0.0247
21 ACQUIRED ATTR AMYLOIDOSIS 1 0.0244
22 APPLICATION SITE COLDNESS 2 0.0235
23 APPLICATION SITE NODULE 3 0.0219
24 MANUFACTURING PRODUCTION ISSUE 2 0.0192
25 HERPES ZOSTER INFECTION NEUROLOGICAL 3 0.0189
26 EXPOSURE VIA INHALATION 4 0.0185
27 APPLICATION SITE PARAESTHESIA 24 0.0184
28 PAIN THRESHOLD DECREASED 2 0.0164
29 APPLICATION SITE HAEMATOMA 3 0.0164
30 APPLICATION SITE BURN 79 0.0160
31 BURNING MOUTH SYNDROME 9 0.0159
32 APPLICATION SITE DISCOMFORT 28 0.0156
33 DIABETIC NEUROPATHY 72 0.0145
34 COMPLEX REGIONAL PAIN SYNDROME 20 0.0135
35 PLANTAR ERYTHEMA 3 0.0121
36 APPLICATION SITE WOUND 2 0.0121
37 ADMINISTRATION SITE OEDEMA 1 0.0116
38 APPLICATION SITE ECZEMA 1 0.0115
39 POST HERPETIC NEURALGIA 15 0.0104
40 ALLODYNIA 12 0.0103
41 APPLICATION SITE VESICLES 65 0.0100
42 APPLICATION SITE ULCER 7 0.0099
43 GLUCOSE TOLERANCE IMPAIRED 57 0.0096
44 HISTAMINE INTOLERANCE 2 0.0088
45 APPLICATION SITE INFLAMMATION 12 0.0087
46 CRYOGLOBULINAEMIA 6 0.0084
47 HYPEREMESIS GRAVIDARUM 3 0.0078
48 GALLBLADDER OBSTRUCTION 2 0.0075
49 OCCUPATIONAL EXPOSURE TO PRODUCT 47 0.0073
50 FOETAL HYPOKINESIA 5 0.0071
51 EXPOSURE VIA EYE CONTACT 3 0.0071
52 CEREBRAL VASOCONSTRICTION 5 0.0068
53 RESPIRATORY TRACT IRRITATION 7 0.0067
54 APPLICATION SITE ERYTHEMA 172 0.0066
55 IMMUNE THROMBOCYTOPENIA 30 0.0065
56 PURPURA 57 0.0064
57 DREAMY STATE 2 0.0062
58 SLEEP DEFICIT 13 0.0061
59 CHEMICAL INJURY 5 0.0061
60 APPLICATION SITE SWELLING 30 0.0060
61 HYPOCHROMIC ANAEMIA 6 0.0059
62 APPLICATION SITE INDURATION 1 0.0059
63 CHRONIC LEFT VENTRICULAR FAILURE 2 0.0056
64 APPLICATION SITE PUSTULES 2 0.0055
65 BIOPSY LUNG 2 0.0054
66 HYPERLIPIDAEMIA 63 0.0053
67 PRODUCT ADMINISTERED BY WRONG PERSON 2 0.0052
68 APPLICATION SITE DISCOLOURATION 21 0.0052
69 SPINAL CORD INJURY 9 0.0052
70 MAGNETIC RESONANCE IMAGING ABNORMAL 6 0.0050
71 ANTICHOLINERGIC SYNDROME 8 0.0050
72 APPLICATION SITE HYPERSENSITIVITY 6 0.0049
73 IMPAIRED QUALITY OF LIFE 71 0.0049
74 PROLONGED LABOUR 3 0.0049
75 ANAL ULCER 4 0.0049
76 BURNING SENSATION 343 0.0049
77 APPLICATION SITE LACERATION 2 0.0048
78 THERMAL BURN 34 0.0048
79 HOMELESS 2 0.0045
80 BANKRUPTCY 2 0.0044
81 ALLERGY TO ARTHROPOD STING 2 0.0044
82 EPIDERMOLYSIS 2 0.0043
83 PRODUCT APPEARANCE CONFUSION 4 0.0043
84 PRODUCT DOSAGE FORM ISSUE 2 0.0041
85 APPLICATION SITE BRUISE 4 0.0041
86 APPLICATION SITE SCAR 5 0.0040
87 FAECAL VOLUME INCREASED 2 0.0038
88 BURNS THIRD DEGREE 4 0.0038
89 APPLICATION SITE PAPULES 4 0.0038
90 POOR QUALITY SLEEP 77 0.0036
91 INDUCED LABOUR 2 0.0034
92 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 2 0.0032
93 IMPAIRED WORK ABILITY 68 0.0032
94 GLOMERULOSCLEROSIS 2 0.0032
95 PARESIS 7 0.0031
96 ADMINISTRATION SITE SWELLING 1 0.0031
97 HYPERAESTHESIA 25 0.0030
98 ORAL HERPES 57 0.0029
99 BREAST DISCOMFORT 3 0.0029
100 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
101 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
102 HAEMORRHAGE IN PREGNANCY 4 0.0028
103 DRUG MONITORING PROCEDURE NOT PERFORMED 5 0.0028
104 OROMANDIBULAR DYSTONIA 2 0.0027
105 ESCHAR 2 0.0027
106 BLUNTED AFFECT 2 0.0027
107 BLISTER RUPTURE 2 0.0027
108 APPLICATION SITE EXFOLIATION 11 0.0027
109 ACCELERATED HYPERTENSION 1 0.0026
110 PSYCHIATRIC DECOMPENSATION 5 0.0026
111 TONGUE HAEMORRHAGE 3 0.0026
112 CSF PROTEIN INCREASED 2 0.0024
113 OESOPHAGEAL RUPTURE 2 0.0024
114 COUNTERFEIT PRODUCT ADMINISTERED 3 0.0023
115 VASCULAR DEMENTIA 2 0.0023
116 CEREBELLAR ATROPHY 2 0.0023
117 CERUMEN IMPACTION 2 0.0022
118 TRAUMATIC INTRACRANIAL HAEMORRHAGE 2 0.0022
119 PSYCHOGENIC SEIZURE 2 0.0021
120 NEURALGIA 52 0.0021
121 THERAPEUTIC RESPONSE INCREASED 2 0.0021
122 PANNICULITIS 5 0.0021
123 GENERALISED ANXIETY DISORDER 3 0.0020
124 BONE DENSITY DECREASED 62 0.0020
125 KERATITIS 6 0.0020
126 ABDOMINAL INJURY 1 0.0019
127 PRODUCT COMMINGLING 2 0.0019
128 SKIN DISORDER 62 0.0019
129 GAMBLING DISORDER 5 0.0018
130 ACARODERMATITIS 2 0.0018
131 APPLICATION SITE HAEMORRHAGE 5 0.0018
132 AMNIOTIC FLUID VOLUME DECREASED 1 0.0018
133 PRODUCT SELECTION ERROR 2 0.0018
134 CARBON DIOXIDE DECREASED 2 0.0017
135 BREAKTHROUGH PAIN 4 0.0017
136 LUMBAR RADICULOPATHY 2 0.0017
137 GLOSSITIS 6 0.0017
138 UPPER RESPIRATORY TRACT INFLAMMATION 2 0.0017
139 EYE OEDEMA 4 0.0016
140 SENSITIVE SKIN 12 0.0016
141 LOSS OF CONTROL OF LEGS 6 0.0016
142 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
143 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
144 THROMBOCYTOPENIC PURPURA 2 0.0015
145 COMPULSIVE SHOPPING 3 0.0015
146 LIVEDO RETICULARIS 3 0.0014
147 SELF-INJURIOUS IDEATION 6 0.0014
148 ELECTRIC SHOCK SENSATION 4 0.0014
149 MAST CELL ACTIVATION SYNDROME 2 0.0014
150 APPLICATION SITE REACTION 10 0.0014
151 PERONEAL NERVE PALSY 8 0.0014
152 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
153 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
154 APALLIC SYNDROME 1 0.0014
155 AXILLARY PAIN 2 0.0013
156 LARGE INTESTINAL OBSTRUCTION 3 0.0013
157 ARTERIAL INJURY 1 0.0013
158 MENTAL FATIGUE 2 0.0013
159 GASTRIC POLYPS 3 0.0013
160 ORAL PRURITUS 3 0.0013
161 HERPES ZOSTER 75 0.0013
162 CELLULITIS 65 0.0013
163 QUALITY OF LIFE DECREASED 17 0.0013
164 RESPIRATORY ALKALOSIS 2 0.0012
165 FEELING HOT 75 0.0012
166 ADRENAL MASS 1 0.0012
167 DRUG ERUPTION 21 0.0012
168 CHEMICAL BURN OF SKIN 3 0.0012
169 SEDATION COMPLICATION 3 0.0012
170 CATARACT 70 0.0012
171 ALLERGIC SINUSITIS 1 0.0012
172 BLOOD CHLORIDE INCREASED 2 0.0012
173 THERAPY NON-RESPONDER 52 0.0012
174 OCULAR ICTERUS 5 0.0012
175 SLEEP APNOEA SYNDROME 22 0.0012
176 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
177 PERSONALITY DISORDER 3 0.0011
178 ALOPECIA AREATA 2 0.0011
179 ANGIONEUROTIC OEDEMA 3 0.0011
180 JOINT ARTHROPLASTY 2 0.0011
181 ANAEMIA OF CHRONIC DISEASE 1 0.0011
182 ESSENTIAL HYPERTENSION 2 0.0011
183 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
184 APPLICATION SITE DERMATITIS 1 0.0011
185 HYPERTENSIVE HEART DISEASE 2 0.0011
186 DRUG TOLERANCE DECREASED 3 0.0011
187 LIMB DISCOMFORT 33 0.0011
188 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0011
189 RHEUMATOID FACTOR POSITIVE 6 0.0010
190 BLISTER 58 0.0010
191 HYPOGEUSIA 2 0.0010
192 TORSADE DE POINTES 8 0.0010
193 JOINT NOISE 2 0.0010
194 APPLICATION SITE RASH 14 0.0010
195 APPLICATION SITE PRURITUS 23 0.0010
196 ERYSIPELAS 5 0.0010
197 LOSS OF EMPLOYMENT 3 0.0010
198 IMPULSE-CONTROL DISORDER 2 0.0010
199 VISUAL FIELD DEFECT 7 0.0010
200 MICROCYTIC ANAEMIA 2 0.0010
201 NON-CARDIAC CHEST PAIN 3 0.0009
202 NEUROGENIC BLADDER 2 0.0009
203 CUSHINGOID 3 0.0009
204 MONOPLEGIA 4 0.0009
205 RENAL TUBULAR ACIDOSIS 2 0.0009
206 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
207 PHYSICAL DISABILITY 4 0.0009
208 APPLICATION SITE URTICARIA 2 0.0009
209 NEONATAL RESPIRATORY DISTRESS SYNDROME 3 0.0008
210 ACUTE LUNG INJURY 1 0.0008
211 PARAESTHESIA ORAL 12 0.0008
212 GLAUCOMA 16 0.0008
213 ORAL INTAKE REDUCED 2 0.0008
214 ASTHMATIC CRISIS 3 0.0008
215 NO THERAPEUTIC RESPONSE 10 0.0008
216 APPLICATION SITE IRRITATION 10 0.0008
217 HYPERPARATHYROIDISM SECONDARY 2 0.0008
218 ECONOMIC PROBLEM 12 0.0008
219 LIVER FUNCTION TEST INCREASED 17 0.0008
220 APPLICATION SITE EROSION 1 0.0008
221 CATHETER SITE PAIN 2 0.0008
222 ABDOMINAL OPERATION 1 0.0008
223 ADJUSTMENT DISORDER 1 0.0008
224 PARALYSIS 11 0.0008
225 ANAEMIA POSTOPERATIVE 1 0.0008
226 SKIN ODOUR ABNORMAL 3 0.0008
227 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54 0.0008
228 RADICULOPATHY 2 0.0008
229 PAIN IN EXTREMITY 222 0.0008
230 ALCOHOL ABUSE 2 0.0007
231 SENSORY DISTURBANCE 12 0.0007
232 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
233 BREAST MASS 5 0.0007
234 SKIN DISCOMFORT 2 0.0007
235 CONTUSION 70 0.0007
236 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
237 HYPERTENSIVE CRISIS 8 0.0007
238 THROAT IRRITATION 32 0.0007
239 TONGUE DISCOMFORT 3 0.0007
240 PAIN 434 0.0007
241 INTERVERTEBRAL DISC DISORDER 3 0.0007
242 VOMITING PROJECTILE 2 0.0007
243 FAECES SOFT 5 0.0007
244 LUMBAR SPINAL STENOSIS 2 0.0007
245 BRADYKINESIA 4 0.0007
246 INFUSION SITE REACTION 2 0.0007
247 VARICES OESOPHAGEAL 2 0.0007
248 PARAESTHESIA 104 0.0007
249 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
250 EMBOLISM VENOUS 2 0.0007
251 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 12 0.0007
252 CHEST X-RAY ABNORMAL 2 0.0007
253 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
254 RECTAL CANCER 2 0.0007
255 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
256 LARYNGEAL OEDEMA 4 0.0006
257 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
258 NEPHROGENIC ANAEMIA 3 0.0006
259 PRE-EXISTING CONDITION IMPROVED 4 0.0006
260 OSTEOARTHRITIS 27 0.0006
261 SPINAL COLUMN STENOSIS 3 0.0006
262 POLYMYALGIA RHEUMATICA 2 0.0006
263 HYPOAESTHESIA 94 0.0006
264 ORTHOPNOEA 2 0.0006
265 LOOSE TOOTH 2 0.0006
266 RHINITIS 5 0.0006
267 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
268 PRESYNCOPE 15 0.0006
269 SMALL FOR DATES BABY 3 0.0006
270 ATAXIA 7 0.0006
271 APPLICATION SITE DRYNESS 2 0.0006
272 LEFT VENTRICULAR FAILURE 2 0.0006
273 TRISMUS 3 0.0006
274 VIITH NERVE PARALYSIS 2 0.0006
275 LYMPHOEDEMA 4 0.0006
276 EAR PRURITUS 2 0.0006
277 POLYARTHRITIS 3 0.0006
278 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
279 HAEMORRHAGIC DIATHESIS 2 0.0006
280 PRODUCT SUPPLY ISSUE 4 0.0006
281 ALCOHOL USE 2 0.0005
282 NECROSIS 3 0.0005
283 ACCIDENTAL DEATH 1 0.0005
284 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
285 BEDRIDDEN 7 0.0005
286 CHROMATURIA 12 0.0005
287 SKIN ATROPHY 3 0.0005
288 HAEMOLYSIS 4 0.0005
289 ATELECTASIS 5 0.0005
290 RALES 3 0.0005
291 METABOLIC DISORDER 3 0.0005
292 SKIN BURNING SENSATION 37 0.0005
293 SKIN WARM 3 0.0005
294 EJECTION FRACTION DECREASED 8 0.0005
295 SWOLLEN TONGUE 16 0.0005
296 WOUND SECRETION 2 0.0005
297 SLEEP DISORDER 36 0.0005
298 PERIPHERAL COLDNESS 7 0.0005
299 LIGAMENT SPRAIN 5 0.0005
300 NASAL DISCOMFORT 4 0.0005
301 MYOCLONUS 6 0.0005
302 OESOPHAGEAL CANDIDIASIS 2 0.0005
303 CEREBRAL ATROPHY 2 0.0005
304 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
305 END STAGE RENAL DISEASE 9 0.0005
306 BRONCHOSPASM 7 0.0005
307 TRIGGER FINGER 2 0.0005
308 TEMPERATURE INTOLERANCE 5 0.0005
309 NEUROPATHY PERIPHERAL 46 0.0005
310 SOCIAL PROBLEM 2 0.0005
311 ANAL PRURITUS 1 0.0005
312 ACCIDENTAL EXPOSURE 2 0.0005
313 INFUSION SITE SWELLING 3 0.0005
314 ONYCHOMADESIS 2 0.0005
315 BUNDLE BRANCH BLOCK LEFT 2 0.0005
316 INADEQUATE ANALGESIA 4 0.0005
317 ANAPHYLACTIC REACTION 26 0.0005
318 CIRCULATORY COLLAPSE 8 0.0005
319 APPLICATION SITE SCAB 1 0.0005
320 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
321 SEDATION 12 0.0005
322 TONGUE DISCOLOURATION 2 0.0005
323 ERYTHEMA 94 0.0005
324 PULMONARY FUNCTION TEST DECREASED 2 0.0005
325 WEIGHT INCREASED 102 0.0005
326 SPINAL OSTEOARTHRITIS 4 0.0005
327 PARONYCHIA 2 0.0005
328 MUSCULOSKELETAL CHEST PAIN 7 0.0005
329 LIP SWELLING 15 0.0004
330 WHEELCHAIR USER 2 0.0004
331 THERAPY PARTIAL RESPONDER 7 0.0004
332 URINARY TRACT DISORDER 2 0.0004
333 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
334 PRODUCT LABEL ISSUE 3 0.0004
335 IMPAIRED GASTRIC EMPTYING 6 0.0004
336 ABDOMINAL HERNIA 2 0.0004
337 EXOSTOSIS 4 0.0004
338 SKIN DISCOLOURATION 20 0.0004
339 ISCHAEMIA 2 0.0004
340 TOOTH LOSS 9 0.0004
341 SYNOVIAL CYST 2 0.0004
342 DELIRIUM 15 0.0004
343 ORAL DISCOMFORT 6 0.0004
344 FORMICATION 3 0.0004
345 DEFAECATION URGENCY 3 0.0004
346 SKIN REACTION 6 0.0004
347 PAPULE 3 0.0004
348 SKIN ULCER 11 0.0004
349 SKIN ABRASION 2 0.0004
350 COLITIS MICROSCOPIC 2 0.0004
351 INSOMNIA 112 0.0004
352 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
353 ANHEDONIA 11 0.0004
354 FINGER DEFORMITY 2 0.0004
355 HYPERTENSION 87 0.0004
356 VITAMIN D DEFICIENCY 4 0.0004
357 DISCOMFORT 25 0.0004
358 THROAT TIGHTNESS 11 0.0004
359 BREATH SOUNDS ABNORMAL 2 0.0004
360 WITHDRAWAL SYNDROME 17 0.0004
361 SKIN HAEMORRHAGE 6 0.0004
362 HYPERVOLAEMIA 2 0.0004
363 BLADDER DISORDER 4 0.0004
364 CONFUSIONAL STATE 65 0.0004
365 HEPATIC ENZYME ABNORMAL 2 0.0004
366 HYPOAESTHESIA ORAL 6 0.0004
367 DERMATITIS ALLERGIC 5 0.0004
368 PATHOLOGICAL FRACTURE 2 0.0004
369 APPENDICITIS PERFORATED 1 0.0004
370 MOTOR DYSFUNCTION 4 0.0004
371 PETIT MAL EPILEPSY 2 0.0004
372 ABDOMINAL INFECTION 1 0.0004
373 AORTIC ARTERIOSCLEROSIS 1 0.0004
374 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
375 SKIN NECROSIS 2 0.0004
376 ACTINIC KERATOSIS 1 0.0004
377 FAILURE TO THRIVE 2 0.0004
378 RESTLESS LEGS SYNDROME 7 0.0004
379 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
380 EYE IRRITATION 22 0.0004
381 HALLUCINATION, VISUAL 8 0.0004
382 ULCER 6 0.0004
383 ADVERSE REACTION 5 0.0004
384 ANORECTAL DISCOMFORT 2 0.0004
385 BREAST PAIN 4 0.0004
386 TREATMENT FAILURE 31 0.0004
387 ALCOHOL POISONING 1 0.0004
388 CHEILITIS 2 0.0004
389 RASH PRURITIC 20 0.0004
390 ACCIDENTAL EXPOSURE TO PRODUCT 38 0.0004
391 ABDOMINAL RIGIDITY 1 0.0004
392 BIPOLAR DISORDER 4 0.0004
393 BLOOD CREATININE INCREASED 24 0.0004
394 PRODUCT PRESCRIBING ISSUE 8 0.0004
395 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
396 ESCHERICHIA INFECTION 3 0.0004
397 HYPERKERATOSIS 2 0.0004
398 COAGULOPATHY 6 0.0004
399 GAIT INABILITY 12 0.0004
400 ACUTE PULMONARY OEDEMA 2 0.0004
401 INFUSION SITE ERYTHEMA 3 0.0004
402 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
403 SCAR 6 0.0004
404 INTERNAL HAEMORRHAGE 4 0.0003
405 MUSCULOSKELETAL DISCOMFORT 6 0.0003
406 EXERCISE TOLERANCE DECREASED 2 0.0003
407 BLOOD URIC ACID INCREASED 2 0.0003
408 HYPOKINESIA 5 0.0003
409 GASTROENTERITIS 5 0.0003
410 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
411 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
412 PRODUCT COMMUNICATION ISSUE 3 0.0003
413 PRODUCT ADHESION ISSUE 12 0.0003
414 CARDIAC PACEMAKER INSERTION 2 0.0003
415 GOUT 6 0.0003
416 MUSCLE SPASMS 61 0.0003
417 OROPHARYNGEAL DISCOMFORT 3 0.0003
418 ACNE CYSTIC 1 0.0003
419 OEDEMA 18 0.0003
420 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
421 PERIPHERAL SWELLING 51 0.0003
422 CORONARY ARTERY DISEASE 10 0.0003
423 DISORIENTATION 13 0.0003
424 EYE PRURITUS 11 0.0003
425 DYSURIA 12 0.0003
426 MENISCUS INJURY 2 0.0003
427 UROSEPSIS 3 0.0003
428 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
429 TENDON RUPTURE 4 0.0003
430 SCOLIOSIS 2 0.0003
431 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
432 SQUAMOUS CELL CARCINOMA 3 0.0003
433 MULTIPLE INJURIES 2 0.0003
434 SPINAL DISORDER 3 0.0003
435 SPUTUM DISCOLOURED 3 0.0003
436 HYPERKALAEMIA 11 0.0003
437 SCIATICA 5 0.0003
438 HYPERSENSITIVITY 58 0.0003
439 INFUSION SITE PAIN 4 0.0003
440 MUSCLE TIGHTNESS 5 0.0003
441 ATRIAL FIBRILLATION 30 0.0003
442 DIPLOPIA 8 0.0003
443 BLOOD POTASSIUM INCREASED 5 0.0003
444 BACK DISORDER 5 0.0003
445 METASTASES TO BONE 5 0.0003
446 DYSGRAPHIA 2 0.0003
447 DISABILITY 6 0.0003
448 PRODUCT FORMULATION ISSUE 2 0.0003
449 CHRONIC KIDNEY DISEASE 23 0.0003
450 HAEMATOCRIT DECREASED 6 0.0003
451 DRUG INEFFECTIVE 398 0.0003
452 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
453 CARDIAC FAILURE ACUTE 2 0.0003
454 ANXIETY DISORDER 1 0.0003
455 BRONCHIECTASIS 2 0.0003
456 UVEITIS 4 0.0003
457 TOOTH ABSCESS 3 0.0003
458 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
459 ANGIOEDEMA 13 0.0003
460 ABNORMAL LOSS OF WEIGHT 2 0.0003
461 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
462 ECCHYMOSIS 2 0.0003
463 SKIN LESION 8 0.0003
464 JOINT EFFUSION 2 0.0003
465 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
466 MENTAL STATUS CHANGES 8 0.0003
467 PRODUCT ODOUR ABNORMAL 3 0.0003
468 CARPAL TUNNEL SYNDROME 4 0.0003
469 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
470 PRODUCT USE ISSUE 53 0.0003
471 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
472 TACHYCARDIA 25 0.0003
473 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 57 0.0003
474 BODY HEIGHT DECREASED 3 0.0003
475 BREAST CANCER METASTATIC 3 0.0003
476 BALANCE DISORDER 24 0.0003
477 DERMATITIS BULLOUS 2 0.0003
478 MENTAL DISORDER 12 0.0003
479 RASH PUSTULAR 2 0.0003
480 DENTAL CARIES 3 0.0003
481 FOOT DEFORMITY 3 0.0003
482 CEREBRAL DISORDER 2 0.0003
483 HAEMATOMA 7 0.0003
484 NEOPLASM MALIGNANT 18 0.0003
485 COUGH 75 0.0003
486 BLOOD CALCIUM DECREASED 3 0.0003
487 DYSPNOEA EXERTIONAL 10 0.0003
488 IMPAIRED DRIVING ABILITY 3 0.0003
489 OSTEOPENIA 4 0.0003
490 DERMATITIS CONTACT 3 0.0003
491 SUICIDAL IDEATION 24 0.0003
492 INSURANCE ISSUE 4 0.0003
493 BOWEL MOVEMENT IRREGULARITY 2 0.0003
494 NEOPLASM 3 0.0003
495 SEROTONIN SYNDROME 5 0.0003
496 RENAL FAILURE CHRONIC 2 0.0003
497 DISTURBANCE IN ATTENTION 14 0.0003
498 CONCUSSION 2 0.0003
499 CHOKING 5 0.0003
500 SPINAL PAIN 3 0.0003
501 GAIT DISTURBANCE 49 0.0003
502 AFFECTIVE DISORDER 2 0.0003
503 RENAL CYST 2 0.0003
504 TRICUSPID VALVE INCOMPETENCE 2 0.0003
505 PREMATURE DELIVERY 4 0.0003
506 ADVERSE EVENT 23 0.0002
507 MUSCULOSKELETAL PAIN 13 0.0002
508 MENTAL IMPAIRMENT 6 0.0002
509 SCHIZOPHRENIA 3 0.0002
510 FEEDING DISORDER 5 0.0002
511 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
512 ANGINA PECTORIS 7 0.0002
513 ABNORMAL FAECES 2 0.0002
514 SMALL INTESTINAL OBSTRUCTION 3 0.0002
515 ANAPHYLACTOID REACTION 1 0.0002
516 CONSTIPATION 53 0.0002
517 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
518 GENERALISED OEDEMA 3 0.0002
519 SPINAL COMPRESSION FRACTURE 2 0.0002
520 CYST 3 0.0002
521 TOOTH EXTRACTION 3 0.0002
522 SKIN IRRITATION 11 0.0002
523 CONDITION AGGRAVATED 73 0.0002
524 DYSSTASIA 7 0.0002
525 HAEMODIALYSIS 2 0.0002
526 MUSCLE ATROPHY 3 0.0002
527 RENAL INJURY 7 0.0002
528 VITAMIN D DECREASED 2 0.0002
529 ALCOHOLISM 1 0.0002
530 ROTATOR CUFF SYNDROME 3 0.0002
531 PRODUCT CONTAINER ISSUE 2 0.0002
532 HYPERHIDROSIS 30 0.0002
533 CHEST PAIN 43 0.0002
534 LACRIMATION INCREASED 7 0.0002
535 RASH GENERALISED 6 0.0002
536 PRURITUS GENERALISED 5 0.0002
537 NIGHTMARE 8 0.0002
538 PRODUCTIVE COUGH 11 0.0002
539 NODULE 3 0.0002
540 PRODUCT QUALITY ISSUE 31 0.0002
541 BLOOD CALCIUM INCREASED 2 0.0002
542 GASTRITIS 6 0.0002
543 IMMUNOSUPPRESSION 2 0.0002
544 FEMUR FRACTURE 7 0.0002
545 SKIN EXFOLIATION 19 0.0002
546 JOINT RANGE OF MOTION DECREASED 3 0.0002
547 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
548 SNEEZING 5 0.0002
549 ANAL INCONTINENCE 2 0.0002
550 SURGERY 13 0.0002
551 LEUKOCYTOSIS 4 0.0002
552 DRUG EFFECT INCOMPLETE 8 0.0002
553 MUSCULAR WEAKNESS 25 0.0002
554 FALL 73 0.0002
555 INCREASED TENDENCY TO BRUISE 2 0.0002
556 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
557 INTENTIONAL PRODUCT MISUSE 19 0.0002
558 IRON DEFICIENCY ANAEMIA 2 0.0002
559 FLUID RETENTION 11 0.0002
560 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
561 FATIGUE 168 0.0002
562 DEEP VEIN THROMBOSIS 14 0.0002
563 HAEMOPTYSIS 6 0.0002
564 SWELLING FACE 14 0.0002
565 APHONIA 3 0.0002
566 EMOTIONAL DISTRESS 26 0.0002
567 WOUND 6 0.0002
568 BLOOD CHOLESTEROL INCREASED 10 0.0002
569 HEPATIC ENCEPHALOPATHY 2 0.0002
570 DRUG INTERACTION 34 0.0002
571 MIDDLE INSOMNIA 4 0.0002
572 INFLAMMATION 11 0.0002
573 PHOTOPHOBIA 4 0.0002
574 ABORTION INDUCED 2 0.0002
575 LEUKAEMIA 2 0.0002
576 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
577 PRODUCT PACKAGING ISSUE 2 0.0002
578 URINARY RETENTION 7 0.0002
579 ACUTE RESPIRATORY FAILURE 4 0.0002
580 AFFECT LABILITY 2 0.0002
581 APHAGIA 1 0.0002
582 HERNIA 4 0.0002
583 LOCALISED INFECTION 5 0.0002
584 ERUCTATION 4 0.0002
585 PRESCRIBED OVERDOSE 4 0.0002
586 DIZZINESS POSTURAL 2 0.0002
587 OEDEMA PERIPHERAL 25 0.0002
588 RENAL TUBULAR NECROSIS 2 0.0002
589 BODY TEMPERATURE DECREASED 2 0.0002
590 SWELLING 19 0.0002
591 URINARY INCONTINENCE 6 0.0002
592 WHEEZING 12 0.0002
593 RASH MACULAR 7 0.0002
594 MYALGIA 34 0.0002
595 SALIVARY HYPERSECRETION 2 0.0002
596 BRAIN INJURY 2 0.0002
597 HEPATIC FAILURE 6 0.0002
598 HYPOXIA 7 0.0002
599 EMPHYSEMA 2 0.0002
600 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
601 HYPOTHERMIA 2 0.0002
602 TASTE DISORDER 4 0.0002
603 DRUG INTOLERANCE 19 0.0002
604 AMMONIA INCREASED 1 0.0002
605 HIP ARTHROPLASTY 3 0.0002
606 HYPOPHAGIA 5 0.0002
607 DRUG ADMINISTRATION ERROR 6 0.0002
608 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
609 TENDONITIS 3 0.0002
610 PERITONITIS 4 0.0002
611 TREMOR 32 0.0002
612 TENDERNESS 2 0.0002
613 PETECHIAE 2 0.0002
614 BRAIN FOG 3 0.0002
615 DYSPNOEA 108 0.0002
616 AGITATION 14 0.0002
617 NASOPHARYNGITIS 35 0.0002
618 BLOOD PRESSURE INCREASED 29 0.0002
619 SCRATCH 2 0.0002
620 JOINT DISLOCATION 2 0.0002
621 PNEUMOTHORAX 3 0.0002
622 RENAL FAILURE 25 0.0002
623 RECTAL HAEMORRHAGE 8 0.0002
624 HALLUCINATION 14 0.0002
625 PAIN OF SKIN 5 0.0002
626 PRURITUS 71 0.0002
627 DEPRESSION 42 0.0002
628 ABDOMINAL PAIN UPPER 38 0.0002
629 GASTROINTESTINAL PAIN 2 0.0002
630 PHOTOSENSITIVITY REACTION 3 0.0002
631 DRUG LEVEL INCREASED 3 0.0002
632 RESPIRATORY DISTRESS 5 0.0002
633 ABNORMAL DREAMS 5 0.0002
634 BLOOD PRESSURE DECREASED 12 0.0002
635 PROCEDURAL PAIN 5 0.0002
636 NERVE INJURY 2 0.0002
637 FEELING COLD 5 0.0002
638 BLOOD UREA INCREASED 3 0.0002
639 PULMONARY EMBOLISM 17 0.0002
640 ORAL PAIN 4 0.0002
641 ANGIOPATHY 1 0.0002
642 OCULAR DISCOMFORT 2 0.0002
643 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
644 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
645 DIZZINESS 88 0.0002
646 SCAB 2 0.0002
647 THERAPY CESSATION 9 0.0002
648 RED BLOOD CELL COUNT DECREASED 5 0.0002
649 PARANOIA 3 0.0002
650 OFF LABEL USE 152 0.0002
651 EYELID OEDEMA 2 0.0002
652 CAESAREAN SECTION 2 0.0002
653 SEXUAL DYSFUNCTION 2 0.0002
654 ACUTE KIDNEY INJURY 26 0.0002
655 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
656 ANXIETY 48 0.0002
657 BLOOD IRON DECREASED 2 0.0002
658 BACK PAIN 39 0.0002
659 CEREBRAL HAEMORRHAGE 6 0.0002
660 MACULAR DEGENERATION 2 0.0002
661 MEMORY IMPAIRMENT 23 0.0002
662 ROAD TRAFFIC ACCIDENT 7 0.0002
663 POLYNEUROPATHY 2 0.0002
664 BLOOD PRESSURE FLUCTUATION 4 0.0002
665 THYROID CANCER 2 0.0002
666 GASTROENTERITIS VIRAL 3 0.0002
667 CHEST DISCOMFORT 17 0.0002
668 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
669 HEPATITIS C 2 0.0002
670 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
671 NOCTURIA 2 0.0002
672 RESPIRATORY FAILURE 12 0.0002
673 FIBROMYALGIA 4 0.0002
674 SEIZURE 19 0.0002
675 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
676 SOMNOLENCE 33 0.0002
677 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
678 DYSPEPSIA 16 0.0002
679 CARDIOMEGALY 2 0.0002
680 SPINAL OPERATION 2 0.0002
681 CARDIAC FAILURE CONGESTIVE 13 0.0002
682 ARTHRALGIA 67 0.0002
683 DRY EYE 8 0.0002
684 OXYGEN SATURATION DECREASED 9 0.0002
685 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
686 SECRETION DISCHARGE 2 0.0002
687 HEPATIC CIRRHOSIS 3 0.0002
688 HYPOTENSION 32 0.0002
689 EYE PAIN 9 0.0002
690 BLOOD SODIUM DECREASED 3 0.0002
691 HEAD INJURY 5 0.0002
692 PROTEINURIA 3 0.0002
693 MUSCULOSKELETAL DISORDER 3 0.0002
694 CARDIOVASCULAR DISORDER 4 0.0002
695 MALAISE 69 0.0002
696 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
697 HYPOTHYROIDISM 5 0.0002
698 PULMONARY OEDEMA 7 0.0002
699 ERECTILE DYSFUNCTION 4 0.0002
700 MOVEMENT DISORDER 5 0.0002
701 FEELING ABNORMAL 37 0.0002
702 ANGINA UNSTABLE 1 0.0002
703 HAEMORRHOIDS 3 0.0002
704 SKIN FISSURES 3 0.0002
705 MOBILITY DECREASED 11 0.0002
706 JOINT STIFFNESS 4 0.0002
707 OSTEONECROSIS 5 0.0002
708 PULMONARY CONGESTION 2 0.0002
709 STAPHYLOCOCCAL INFECTION 5 0.0002
710 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
711 DEPRESSED MOOD 8 0.0002
712 BLOOD PRESSURE ABNORMAL 3 0.0002
713 APPETITE DISORDER 1 0.0002
714 BRADYCARDIA 8 0.0002
715 VISUAL ACUITY REDUCED 5 0.0002
716 ASTHMA 17 0.0002
717 SYNCOPE 15 0.0001
718 EYE HAEMORRHAGE 2 0.0001
719 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0001
720 MUSCULOSKELETAL STIFFNESS 13 0.0001
721 BLOOD BILIRUBIN INCREASED 4 0.0001
722 ANGER 5 0.0001
723 VERTIGO 9 0.0001
724 DYSKINESIA 6 0.0001
725 LIMB INJURY 4 0.0001
726 BLINDNESS 6 0.0001
727 TACHYPNOEA 2 0.0001
728 DRUG TOXICITY 2 0.0001
729 MIGRAINE 14 0.0001
730 AKATHISIA 2 0.0001
731 RASH ERYTHEMATOUS 7 0.0001
732 CHILLS 17 0.0001
733 PULMONARY HYPERTENSION 3 0.0001
734 COORDINATION ABNORMAL 2 0.0001
735 URTICARIA 24 0.0001
736 NECK PAIN 8 0.0001
737 DEMENTIA 4 0.0001
738 RENAL FAILURE ACUTE 6 0.0001
739 HEART RATE INCREASED 14 0.0001
740 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
741 FLATULENCE 8 0.0001
742 DIALYSIS 2 0.0001
743 LOSS OF CONSCIOUSNESS 18 0.0001
744 JOINT INJURY 3 0.0001
745 INTENTIONAL DOSE OMISSION 4 0.0001
746 IRRITABLE BOWEL SYNDROME 3 0.0001
747 ARTHRITIS 11 0.0001
748 HYPERSOMNIA 4 0.0001
749 SKIN CANCER 3 0.0001
750 LETHARGY 8 0.0001
751 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
752 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
753 FLUID OVERLOAD 2 0.0001
754 APATHY 2 0.0001
755 ACCIDENTAL OVERDOSE 5 0.0001
756 BONE PAIN 8 0.0001
757 PNEUMONIA 44 0.0001
758 PULMONARY MASS 2 0.0001
759 IMMUNODEFICIENCY 2 0.0001
760 HAEMORRHAGE INTRACRANIAL 2 0.0001
761 EPISTAXIS 10 0.0001
762 PANCREATITIS ACUTE 3 0.0001
763 RASH 58 0.0001
764 IRRITABILITY 8 0.0001
765 BLOOD POTASSIUM DECREASED 4 0.0001
766 INTESTINAL OBSTRUCTION 5 0.0001
767 UNEVALUABLE EVENT 10 0.0001
768 VOMITING 62 0.0001
769 PLEURAL EFFUSION 8 0.0001
770 DEVICE FAILURE 2 0.0001
771 ACIDOSIS 1 0.0001
772 MUSCLE TWITCHING 3 0.0001
773 DEVICE RELATED INFECTION 2 0.0001
774 OROPHARYNGEAL PAIN 12 0.0001
775 LUNG INFECTION 2 0.0001
776 APNOEA 1 0.0001
777 CARDIAC DISORDER 12 0.0001
778 PALPITATIONS 15 0.0001
779 INJURY 9 0.0001
780 ASTHENIA 48 0.0001
781 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
782 DRUG-INDUCED LIVER INJURY 4 0.0001
783 CYANOSIS 2 0.0001
784 PRODUCT USE COMPLAINT 2 0.0001
785 SICKLE CELL ANAEMIA WITH CRISIS 2 0.0001
786 NIGHT SWEATS 4 0.0001
787 NAUSEA 98 0.0001
788 DRY MOUTH 10 0.0001
789 ENCEPHALOPATHY 3 0.0001
790 ABASIA 3 0.0001
791 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
792 AGEUSIA 3 0.0001
793 DYSPHONIA 7 0.0001
794 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
795 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
796 TYPE 2 DIABETES MELLITUS 4 0.0001
797 FACE OEDEMA 2 0.0001
798 PRODUCT COMPLAINT 3 0.0001
799 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
800 SINUSITIS 12 0.0001
801 ANAPHYLACTIC SHOCK 3 0.0001
802 UNRESPONSIVE TO STIMULI 3 0.0001
803 ABDOMINAL PAIN 27 0.0001
804 JOINT SWELLING 14 0.0001
805 DYSPHAGIA 11 0.0001
806 MYOCARDIAL INFARCTION 20 0.0001
807 NEUROTOXICITY 2 0.0001
808 COLD SWEAT 2 0.0001
809 ABDOMINAL DISCOMFORT 19 0.0001
810 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
811 EAR INFECTION 3 0.0001
812 DEHYDRATION 15 0.0001
813 CEREBROVASCULAR ACCIDENT 19 0.0001
814 FEAR 3 0.0001
815 JAUNDICE 3 0.0001
816 WEIGHT DECREASED 31 0.0001
817 COMPLICATION OF DEVICE REMOVAL 2 0.0001
818 RESPIRATORY ARREST 3 0.0001
819 HAEMATOCHEZIA 6 0.0001
820 HYPOKALAEMIA 5 0.0001
821 DIVERTICULITIS 3 0.0001
822 INFLUENZA 12 0.0001
823 HEPATIC STEATOSIS 2 0.0001
824 THINKING ABNORMAL 2 0.0001
825 COGNITIVE DISORDER 5 0.0001
826 HYPONATRAEMIA 6 0.0001
827 FOOT FRACTURE 2 0.0001
828 GASTRIC ULCER 2 0.0001
829 ANAEMIA 20 0.0001
830 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
831 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
832 PANCREATIC CARCINOMA 3 0.0001
833 INFECTION 15 0.0001
834 DECREASED APPETITE 24 0.0001
835 LIVER FUNCTION TEST ABNORMAL 3 0.0001
836 HYPOGLYCAEMIA 5 0.0001
837 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
838 PLASMA CELL MYELOMA 4 0.0001
839 LUNG DISORDER 5 0.0001
840 PSYCHOTIC DISORDER 3 0.0001
841 PYREXIA 35 0.0001
842 ABNORMAL BEHAVIOUR 4 0.0001
843 UPPER LIMB FRACTURE 2 0.0001
844 RESPIRATORY DISORDER 3 0.0001
845 ADVERSE DRUG REACTION 9 0.0001
846 SPINAL FRACTURE 2 0.0001
847 THROMBOSIS 8 0.0001
848 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
849 FLUSHING 10 0.0001
850 PRODUCT PREPARATION ERROR 2 0.0001
851 HEADACHE 61 0.0001
852 OSTEOPOROSIS 4 0.0001
853 POLLAKIURIA 4 0.0001
854 CARDIO-RESPIRATORY ARREST 4 0.0001
855 RENAL IMPAIRMENT 8 0.0001
856 MOUTH ULCERATION 2 0.0001
857 BRONCHITIS 7 0.0001
858 EATING DISORDER 2 0.0001
859 DISEASE PROGRESSION 11 0.0001
860 DRUG EFFECT DECREASED 5 0.0001
861 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
862 FAECES DISCOLOURED 2 0.0001
863 PRODUCT DISPENSING ERROR 2 0.0001
864 CHOLELITHIASIS 3 0.0001
865 IMPAIRED HEALING 3 0.0001
866 MELAENA 2 0.0001
867 TRANSAMINASES INCREASED 2 0.0001
868 RASH MACULO-PAPULAR 2 0.0001
869 DIARRHOEA 58 0.0001
870 GLOSSODYNIA 2 0.0001
871 HEART RATE IRREGULAR 2 0.0001
872 URINARY TRACT INFECTION 15 0.0001
873 ILLNESS 9 0.0001
874 CARDIAC FAILURE 7 0.0001
875 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
876 PERICARDIAL EFFUSION 2 0.0001
877 ABDOMINAL DISTENSION 9 0.0001
878 RENAL DISORDER 4 0.0001
879 CARDIAC ARREST 7 0.0001
880 PLATELET COUNT DECREASED 9 0.0001
881 PRODUCT PRESCRIBING ERROR 2 0.0001
882 ACCIDENT 1 0.0001
883 OVERDOSE 18 0.0001
884 HEPATIC CANCER 2 0.0001
885 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
886 CRYING 3 0.0001
887 STOMATITIS 5 0.0001
888 RESTLESSNESS 3 0.0001
889 ALOPECIA 16 0.0001
890 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
891 SEPSIS 9 0.0001
892 EXTRAPYRAMIDAL DISORDER 2 0.0001
893 THROMBOCYTOPENIA 9 0.0001
894 LEUKOPENIA 4 0.0001
895 DYSARTHRIA 3 0.0001
896 ABDOMINAL PAIN LOWER 2 0.0001
897 HAEMOGLOBIN DECREASED 8 0.0001
898 RHINORRHOEA 5 0.0001
899 NERVOUSNESS 4 0.0001
900 ECZEMA 4 0.0001
901 MUCOSAL INFLAMMATION 2 0.0001
902 DERMATITIS ATOPIC 4 0.0001
903 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
904 DRY SKIN 10 0.0001
905 DEATH 64 0.0001
906 FREQUENT BOWEL MOVEMENTS 2 0.0001
907 ACUTE HEPATIC FAILURE 1 0.0001
908 ARTHROPATHY 4 0.0001
909 MEDICATION ERROR 4 0.0001
910 RHABDOMYOLYSIS 3 0.0001
911 TARDIVE DYSKINESIA 2 0.0001
912 PAIN IN JAW 2 0.0001
913 THERAPY INTERRUPTED 5 0.0001
914 PRODUCT SUBSTITUTION ISSUE 4 0.0001
915 ANOSMIA 1 0.0001
916 DRUG WITHDRAWAL SYNDROME 6 0.0001
917 NASAL CONGESTION 4 0.0001
918 ASCITES 2 0.0001
919 ACUTE MYOCARDIAL INFARCTION 2 0.0001
920 LABORATORY TEST ABNORMAL 2 0.0001
921 DYSGEUSIA 5 0.0001
922 APHASIA 2 0.0001
923 NEUTROPENIA 9 0.0001
924 THERAPEUTIC RESPONSE DECREASED 4 0.0001
925 DIABETES MELLITUS 5 0.0001
926 NEPHROLITHIASIS 3 0.0001
927 TINNITUS 3 0.0001
928 ANKLE FRACTURE 1 0.0001
929 NERVOUS SYSTEM DISORDER 2 0.0001
930 ARRHYTHMIA 3 0.0001
931 OCULAR HYPERAEMIA 3 0.0001
932 COMA 3 0.0001
933 CYSTITIS 2 0.0001
934 MULTIPLE SCLEROSIS 3 0.0001
935 COVID-19 11 0.0001
936 ABSCESS 1 0.0001
937 METABOLIC ACIDOSIS 2 0.0001
938 BLOOD GLUCOSE DECREASED 3 0.0001
939 AMNESIA 4 0.0001
940 EYE DISORDER 2 0.0001
941 INFLUENZA LIKE ILLNESS 5 0.0001
942 EXPIRED PRODUCT ADMINISTERED 2 0.0001
943 AGGRESSION 3 0.0001
944 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
945 HAEMATURIA 2 0.0001
946 BLOOD GLUCOSE INCREASED 11 0.0001
947 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
948 GASTRIC DISORDER 2 0.0001
949 VISION BLURRED 8 0.0001
950 HAEMORRHAGE 6 0.0001
951 PRODUCT STORAGE ERROR 5 0.0001
952 LYMPHADENOPATHY 2 0.0001
953 VISUAL IMPAIRMENT 7 0.0001
954 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
955 DRUG DEPENDENCE 9 0.0001
956 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
957 PANIC ATTACK 2 0.0001
958 PSORIASIS 7 0.0001
959 HOT FLUSH 4 0.0001
960 SUICIDE ATTEMPT 3 0.0000
961 ILL-DEFINED DISORDER 3 0.0000
962 DRUG DOSE OMISSION 8 0.0000
963 HYPOACUSIS 2 0.0000
964 SEPTIC SHOCK 2 0.0000
965 PRODUCT DOSE OMISSION 3 0.0000
966 INFUSION RELATED REACTION 3 0.0000
967 LIVER DISORDER 2 0.0000
968 HEPATIC ENZYME INCREASED 3 0.0000
969 DISEASE RECURRENCE 2 0.0000
970 INTERSTITIAL LUNG DISEASE 2 0.0000
971 UNDERDOSE 3 0.0000
972 ACNE 3 0.0000
973 SPEECH DISORDER 2 0.0000
974 INJECTION SITE HAEMORRHAGE 3 0.0000
975 PANCYTOPENIA 2 0.0000
976 PRODUCT DOSE OMISSION ISSUE 10 0.0000
977 GASTROINTESTINAL DISORDER 3 0.0000
978 NO ADVERSE EVENT 6 0.0000
979 HOSPITALISATION 5 0.0000
980 BREAST CANCER 3 0.0000
981 EXPOSURE DURING PREGNANCY 2 0.0000
982 FEBRILE NEUTROPENIA 2 0.0000
983 DEVICE MALFUNCTION 2 0.0000
984 RHEUMATOID ARTHRITIS 3 0.0000
985 INCORRECT DOSE ADMINISTERED 6 0.0000
986 INJECTION SITE SWELLING 2 0.0000
987 ABORTION SPONTANEOUS 1 0.0000
988 PROSTATE CANCER 2 0.0000
989 INJECTION SITE ERYTHEMA 3 0.0000
990 DRUG ABUSE 2 0.0000
991 TOXICITY TO VARIOUS AGENTS 4 0.0000
992 INJECTION SITE PAIN 6 0.0000